ArticleOncotarget2016

Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.

Yuehong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.